
According to Pentax Medical, the pandemic has accelerated the demand for medical products that can be used without the risk of infection, increasing the competition on the global market for single-use endoscopes.
Gerald Bottero, president of the Japanese Pentax Medical, one of the closest competitors to Danish firm Ambu, writes the following in an email to MedWatch:
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app